USA - NYSE:EVH - US30050B1017 - Common Stock
The current stock price of EVH is 9.02 USD. In the past month the price increased by 2.27%. In the past year, price decreased by -70.04%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 37.1 | 45.31B | ||
DOCS | DOXIMITY INC-CLASS A | 47.67 | 13.30B | ||
WAY | WAYSTAR HOLDING CORP | 33.66 | 6.51B | ||
HTFL | HEARTFLOW INC | N/A | 2.77B | ||
CERT | CERTARA INC | 23.02 | 1.81B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 11.97 | 1.46B | ||
PHR | PHREESIA INC | N/A | 1.45B | ||
SDGR | SCHRODINGER INC | N/A | 1.37B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.36B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
CTEV | CLARITEV CORP | N/A | 1.01B | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 921.31M |
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,500 full-time employees. The company went IPO on 2015-06-05. The firm offers three primary solutions: specialty care management services, total cost of care management and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
EVOLENT HEALTH INC - A
1812 North Moore St, Suite 1705
Arlington VIRGINIA 22203 US
CEO: Seth Blackley
Employees: 4500
Phone: 15713896000
The current stock price of EVH is 9.02 USD. The price decreased by -3.11% in the last trading session.
The exchange symbol of EVOLENT HEALTH INC - A is EVH and it is listed on the New York Stock Exchange, Inc. exchange.
EVH stock is listed on the New York Stock Exchange, Inc. exchange.
18 analysts have analysed EVH and the average price target is 15.98 USD. This implies a price increase of 77.16% is expected in the next year compared to the current price of 9.02. Check the EVOLENT HEALTH INC - A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EVOLENT HEALTH INC - A (EVH) has a market capitalization of 1.06B USD. This makes EVH a Small Cap stock.
EVOLENT HEALTH INC - A (EVH) currently has 4500 employees.
EVOLENT HEALTH INC - A (EVH) has a support level at 8.99 and a resistance level at 9.4. Check the full technical report for a detailed analysis of EVH support and resistance levels.
The Revenue of EVOLENT HEALTH INC - A (EVH) is expected to decline by -24.91% in the next year. Check the estimates tab for more information on the EVH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EVH does not pay a dividend.
EVOLENT HEALTH INC - A (EVH) will report earnings on 2025-11-05, after the market close.
EVOLENT HEALTH INC - A (EVH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
The outstanding short interest for EVOLENT HEALTH INC - A (EVH) is 17.55% of its float. Check the ownership tab for more information on the EVH short interest.
ChartMill assigns a technical rating of 1 / 10 to EVH. When comparing the yearly performance of all stocks, EVH is a bad performer in the overall market: 93.2% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to EVH. EVH has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months EVH reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -101.71% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -7.52% | ||
ROE | -16.46% | ||
Debt/Equity | 0.73 |
18 analysts have analysed EVH and the average price target is 15.98 USD. This implies a price increase of 77.16% is expected in the next year compared to the current price of 9.02.
For the next year, analysts expect an EPS growth of -59.63% and a revenue growth -24.91% for EVH